Trials / Completed
CompletedNCT01642745
Mannitol (Aridol) and Methacholine (Provocholine) Responsiveness
Mannitol and Methacholine Responsiveness: Effects of Deep Inhalations
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Saskatchewan · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will compare the airway responses to two bronchoconstricting agents, mannitol and methacholine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methacholine (Provocholine) | two minutes of aerosol inhalation of concentrations of methacholine ranging from 0.03 - 256mg/mL |
| DRUG | Mannitol (Aridol) | single deep inhalation of dry powder per dose doses range from 0mg - 160mg (cumulative dose range 0mg-635mg). |
| DRUG | Methacholine (Provocholine) | two minutes of aerosol inhalation of concentrations of methacholine ranging from 0.03 - 256mg/mL every 20 seconds a deep inhalation is performed |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-07-17
- Last updated
- 2016-10-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01642745. Inclusion in this directory is not an endorsement.